NovoCure (NVCR) Enterprise Value (2016 - 2025)
Historic Enterprise Value for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to -$1.0 billion.
- NovoCure's Enterprise Value fell 766.78% to -$1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 billion, marking a year-over-year decrease of 766.78%. This contributed to the annual value of -$959.9 million for FY2024, which is 540.92% down from last year.
- As of Q3 2025, NovoCure's Enterprise Value stood at -$1.0 billion, which was down 766.78% from -$911.5 million recorded in Q2 2025.
- Over the past 5 years, NovoCure's Enterprise Value peaked at -$864.4 million during Q1 2021, and registered a low of -$1.0 billion during Q3 2025.
- Its 5-year average for Enterprise Value is -$936.9 million, with a median of -$937.7 million in 2021.
- In the last 5 years, NovoCure's Enterprise Value tumbled by 29671.21% in 2021 and then soared by 917.38% in 2024.
- Over the past 5 years, NovoCure's Enterprise Value (Quarter) stood at -$937.7 million in 2021, then decreased by 3.38% to -$969.4 million in 2022, then increased by 6.07% to -$910.6 million in 2023, then decreased by 5.41% to -$959.9 million in 2024, then fell by 7.67% to -$1.0 billion in 2025.
- Its Enterprise Value was -$1.0 billion in Q3 2025, compared to -$911.5 million in Q2 2025 and -$929.1 million in Q1 2025.